The medavis Group has announced an agreement to acquire medDream, enhancing its portfolio with a universal, zero-footprint medical viewer and marking a significant step towards international expansion.

This acquisition aims to strengthen medavis’s portfolio and expand its global reach. The medDream viewer, known for its high performance across various medical specialties, will become a key component of the medavis referral and patient portal, supporting the entire patient journey.

"Integrating the medDream portfolio aligns perfectly with our goal to expand our international activities over the next few years. We share medDream's belief in the global need for a universal medical viewer. This collaboration is a perfect fit."

medDream co-founders Tomas Dumbliauskas and Vytautas Baublys expressed their pride in the collaboration, highlighting its potential to enhance value in global healthcare.

"The synergy with medavis will speed up product development, expand cloud support, and increase value for existing medDream customers, OEM vendors, and distributors. Our team is excited about the new opportunities this partnership brings.

Together with medavis, we aim to achieve greater success in providing universal access to medical imaging and intelligence."

"With the experienced team in Kaunas, Lithuania, and an innovative product strategy, medDream is well-positioned in the international OEM business, already working with over 400 partners worldwide and showing great growth potential."

The medDream Viewer is certified as a Class IIB medical device under the European Medical Device Regulation (MDR) and has FDA clearance for diagnostic use. Its certifications in other countries emphasize its high quality and safety standards.





Source: medavis.com

Report Abuse